These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1015348)

  • 1. [Clinical problems of alcoholic cirrhosis. III. Laboratory findings, reliability limits and sensitivity in patients with liver cirrhosis in various phases of the disease].
    Knezević S; Wulfe HR; Kneźevic S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):469-81. PubMed ID: 1015348
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical problems of alcoholic cirrhosis. IV. Various phases of liver cirrhosis and reliability limits of laboratory analyses performed in such phases].
    Knezević S; Wulff HR; Knezević S; Madarić M; Falisevac V
    Acta Med Iugosl; 1976; 30(5):483-96. PubMed ID: 1015349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute alcoholic hepatitis (fatty liver hepatitis)].
    Sohnack H
    Wien Med Wochenschr; 1972 Jul; 122(30):460-4. PubMed ID: 5065650
    [No Abstract]   [Full Text] [Related]  

  • 4. [Short-term prognosis of the patient with alcoholic cirrhosis by the use of discriminant function analysis].
    Conti F; Mandelli V; Natangelo R; Cattani F; Tamassia V
    Minerva Med; 1972 Mar; 63(17):994-9. PubMed ID: 5016060
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical problem of alcoholic cirrhosis. II. Attempt at evaluation of individual laboratory findings in patients with liver cirrhosis in various stages of the disease].
    Knezević S; Kallai L; Falisevac V; Hadzic N; Pichler E; Spicer F
    Acta Med Iugosl; 1975; 29(2):135-55. PubMed ID: 1136846
    [No Abstract]   [Full Text] [Related]  

  • 6. [FibroMeters: a family of blood tests for liver fibrosis with high diagnostic performance and applicability in clinical practice].
    Calès P; Boursier J; Oberti F; Gallois Y; Rousselet MC; Moal V; Macchi L; Chevailler A; Lunel F
    Pathol Biol (Paris); 2009 Sep; 57(6):459-62. PubMed ID: 19054629
    [No Abstract]   [Full Text] [Related]  

  • 7. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA; Rodrigo JM; Guix J; Montes F; Wassel A; Aparisi L; Olmo JA; Bixquert M
    Acta Med Port; 1981; 3(1):3-10. PubMed ID: 7304266
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of serum ornithine-carbamyl transferase in patients with liver cirrhosis.
    Ignatowska-Switalska H; Wasowska-Ciszek T
    Pol Med J; 1969; 8(1):57-61. PubMed ID: 5782170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and biopsy studies on the course of fatty liver hepatitis].
    Denk H; Leodolter I; Schnack H; Thaler H
    Wien Klin Wochenschr; 1970 Feb; 82(6):98-101. PubMed ID: 5513205
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma tyrosine level in liver diseases].
    Selmair H; Langness U; Zimmermann J; Herborn U
    Med Klin; 1971 Jun; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Features of hepatic lesions in patients with chronic alcoholic intoxication].
    Polupaev GP; Polenko VK; Khazanov AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):244-9. PubMed ID: 1266489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical diagnosis of alcoholic fatty liver.
    Devenyi P; Rutherdale J; Sereny G; Olin JS
    Am J Gastroenterol; 1970 Dec; 54(6):597-602. PubMed ID: 5504217
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of azathioprin in patients with cirrhosis of the liver.
    Ranek L; Schiödt T; Söborg M; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():49-54. PubMed ID: 4195441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical problems of alcoholic cirrhosis. I. Biological and clinical characteristics of the alcoholic cirrhosis of the liver].
    Knezević S; Falisevac V; Kallai L; Hadzić N; Pichler E; Spicer F
    Acta Med Iugosl; 1974; 28(4):339-53. PubMed ID: 4422443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Liver clearance of bromosulphalein (BSF) in cirrhosis].
    Rodés J; Bordas JM; Bruguera M; Terés J
    Rev Clin Esp; 1968 Nov; 111(3):303-14. PubMed ID: 5736056
    [No Abstract]   [Full Text] [Related]  

  • 18. Antithrombin III in liver disorders.
    Sundar S; Mall RK; Dube B; Singh VP
    J Assoc Physicians India; 1991 Jul; 39(7):522-4. PubMed ID: 1800493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of using a simple cybernetic method for the evaluation of the information capacity of several biochemical tests in chronic diffuse liver diseases].
    Bliuger AF; Krupnikova EZ; Golubev IS; Raĭtsis AB
    Ter Arkh; 1969; 41(10):81-5. PubMed ID: 5359353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.